North America Startup Funding Rounds
Startups raising capital across North America. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 2,693 All time
- Disclosed funding
- $639.4B 2222 disclosed amounts
- Median round
- $25M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
MercorCompany profile Mercor supplies human expertise, evaluation tools and training environments to help AI labs and enterprises improve model performance. Mercor supplies human expertise, evaluation tools and training environments to help AI labs and enterprises improve model performance. | $350M | Series CSeries C+ | AI | United States | Investors | |
CrusoeCompany profile AI infrastructure combining GPU cloud services, managed AI tools, large-scale data centers and modular AI factories for model developers and enterprises. AI infrastructure combining GPU cloud services, managed AI tools, large-scale data centers and modular AI factories for model developers and enterprises. | Undisclosed | Series E initial closeSeries C+ | AI | United States | Investors Mubadala CapitalLeadValor Equity PartnersLead +29137 Ventures1789 CapitalActivate CapitalAltimeterAtreides ManagementBAM ElevateDPR ConstructionFidelity Management & Research CompanyFounders FundFranklin TempletonGalvanizeLong Journey VenturesLowercarbon CapitalM37 ManagementMCJNVIDIAOra GlobalRadical VenturesRibbit CapitalSalesforce VenturesSaquon BarkleySpark CapitalStepStone GroupSupermicroTiger GlobalT. Rowe PriceUpper90Winklevoss CapitalZigg Capital | |
| U UniphoreCompany profile Uniphore develops an enterprise AI platform connecting business data, models and agents. Uniphore develops an enterprise AI platform connecting business data, models and agents. | $260M | Series FSeries C+ | AI | United States | Investors | |
| L LangChainCompany profile LangChain builds open-source frameworks and the LangSmith platform for developing, running and improving AI agents. LangChain builds open-source frameworks and the LangSmith platform for developing, running and improving AI agents. | $125M | Series B | AI | United States | Investors | |
| PA Perceptron AICompany profile Foundation models that help robots and industrial systems understand and act on visual information. Foundation models that help robots and industrial systems understand and act on visual information. | Undisclosed | 2024 pre-seed financing disclosed in 2025Pre-seed | AI | United States | Investors | |
General IntuitionCompany profile Develops multimodal action models trained on gameplay video and player-input telemetry. Develops multimodal action models trained on gameplay video and player-input telemetry. | $133.7M | Seed | AI | United States | Investors | |
| CH Counsel HealthCompany profile Counsel Health combines medical AI and licensed physicians in a virtual care platform for health plans, employers and individual members. Counsel Health combines medical AI and licensed physicians in a virtual care platform for health plans, employers and individual members. | $25M | Series A | Healthtech | United States | Investors | |
| C ClarityCareCompany profile ClarityCare builds AI agents that help health plans, payers and third-party administrators manage utilization review and healthcare administration. ClarityCare builds AI agents that help health plans, payers and third-party administrators manage utilization review and healthcare administration. | $3.5M | Early-stage financingSeed | Healthtech | United States | Investors | |
Kailera TherapeuticsCompany profile Kailera Therapeutics develops oral and injectable medicines for obesity using several GLP-1-based mechanisms. Kailera Therapeutics develops oral and injectable medicines for obesity using several GLP-1-based mechanisms. | $600M | Series B | Biotech | United States | Investors | |
KardiganCompany profile Kardigan develops cardiovascular medicines that target specific biological drivers of heart disease and the patient groups most likely to respond. Kardigan develops cardiovascular medicines that target specific biological drivers of heart disease and the patient groups most likely to respond. | $254M | Series B | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Unsiloed AI, Science Corporation, Garage
143rounds3led - 2Andreessen Horowitz (a16z)
Larridin, Northwood Space, Tutor Intelligence
126rounds31led - 3General Catalyst
Rox, Mercor, Nominal
96rounds15led - 4Sequoia Capital
LangChain, Rox, Nominal
74rounds16led - 5Khosla Ventures
Science Corporation, Imprint, Coframe
71rounds12led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.